MYELOFIBROSIS (PMF)
Clinical trials for MYELOFIBROSIS (PMF) explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS (PMF) trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS (PMF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone marrow cancer: reparixin trial targets hard-to-treat myelofibrosis
Disease control Recruiting nowThis study tests a drug called reparixin in people with a rare bone marrow cancer called myelofibrosis. It is for patients whose disease is advanced or who cannot take standard treatments. The goal is to see if reparixin can shrink the spleen, improve blood counts, and reduce sym…
Matched conditions: MYELOFIBROSIS (PMF)
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: MYELOFIBROSIS (PMF)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 09:03 UTC